Overall rank by patents
#25,220
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 2 technology areas, active 2016–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Sancilio holds 11 US patents across 2 technology areas, rank #25,220 of 50,000 tracked assignees.
Sancilio & Company, Inc. has been granted 11 US utility patents between 2016 and 2018, placing Sancilio & Company, Inc. at rank #25,220 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 25.4 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Sancilio & Company, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Sancilio sits between Sabre Industries Inc. (11 patents, rank #25,216) and Schneider Electric Buildings Americas, Inc. (11 patents, rank #25,224) - the closest US assignees by grant volume. The composite Innovation Score of 28.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 11 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Sancilio & Company, Inc.'s 25.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Sancilio & Company, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Sabre Industries Inc.
11 patents
Sage Global Services Limited
11 patents
Saitama University
11 patents
Salvia BioElectronics B.V.
11 patents
Sandar Industries, Inc.
11 patents
Sassy Woof LLC
11 patents
Saurer Technologies GmbH & Co. KG
11 patents
Schneider Electric Buildings Americas, Inc.
11 patents
Sancilio & Company, Inc.
11 patents
What this shows Sancilio holds 11 patents at rank #25,220, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Sancilio's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 72% higher than 28% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 10 | 90.9% |
| 2018 | 1 | 9.1% |
Top 2 of 2 technology areas
Overall rank by patents
#25,220
Across all tracked assignees
28.6 out of 100
How to use this portfolio
Sancilio's 11 grants land it in the top 72% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.